Tacrolimus is an immunomodulator that prevents the production of interleukin-2 (IL-2) and consequent T-cell activation, which controls the inflammatory process and is used in many inflammatory skin diseases [14]. The gene discussed is IL2; the disease is inflammatory skin disease.